Corrigendum: Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis

Front Cardiovasc Med. 2021 Jul 6:8:723626. doi: 10.3389/fcvm.2021.723626. eCollection 2021.

Authors

Hangying Ying¹, Hongdi Yuan², Xiaomei Tang¹, Wenpu Guo¹, Ruhong Jiang¹, Chenyang Jiang¹

Affiliations

¹ Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang, Department of Cardiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
² Department of Nursing, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Abstract

[This corrects the article DOI: 10.3389/fcvm.2021.641062.].

Keywords: cardiovascular outcome; cardiovascular safety; febuxostat; uric acid-lowering therapy; xanthine oxidase inhibitor.

Copyright © 2021 Ying, Yuan, Tang, Guo, Jiang and Jiang.

Publication types

Published Erratum